In this episode of the Gladden Longevity Podcast, Dr. Jeffrey Gladden and Steve Reiter explore various aspects of longevity, including organ age testing, the pace of aging, multi-drug gerotherapy, the role of GLP-1s, gene therapy, and the importance of lifestyle choices in optimizing health and longevity. They discuss innovative testing methods to assess organ health, the implications of aging rates, and the potential of new therapies to enhance longevity. The conversation emphasizes the significance of understanding individual health metrics and making informed lifestyle choices to achieve optimal health outcomes.
For Audience
- Use code ‘Podcast10’ to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/ !
Listen to this episode here:
Show notes
Takeaways
- Every organ has its own age, impacting overall health.
- Understanding organ age can help tailor longevity strategies.
- New tests can predict health risks before they manifest.
- Multi-drug gerotherapy offers a new approach to aging.
- GLP-1s have benefits beyond weight loss, including heart health.
- Gene therapy may offer new avenues for reversing aging.
- Lifestyle factors remain crucial for longevity and health.
- Regular sauna use significantly reduces all-cause mortality.
- Testing and monitoring are essential for personalized health.
- Combining therapies can enhance the effectiveness of treatments.
Chapters
00:00 Introduction to Age Hacking and Organ Age Testing
01:26 Understanding Organ Age and Proteomic Testing
07:58 The Pace of Aging and Longevity Insights
12:54 Senolytics and Multi-Drug Gerotherapy
23:53 Cleaning the System for Regenerative Therapies
25:46 Rejuvenation Factors and Supplements
26:02 Exploring GLP-1s Beyond Weight Loss
34:39 Gene Therapy and Epigenetic Reprogramming
45:36 Lifestyle Science and Hormesis
Reach out to us!
Website: https://gladdenlongevity.com
Email: podcast@gladdenlongevity.com
Got a question for Dr. Gladden?
We would love to hear from you! Submit it by clicking the button below and it might be answered in our next Q&A episode!
